0
Soleno Therapeutics, Inc. Banner Image

Soleno Therapeutics, Inc. has reached its limit for free report views

Work for Soleno Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Soleno Therapeutics, Inc.

  • Ticker SLNO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Soleno Therapeutics, Inc. Logo Image
  • 1-10 Employees
  • Based in Redwood City, California
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, Diazoxide Choline Controlled-Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase III clinical development program.
Soleno Therapeutics, Inc.

Most Recent Annual Report

Soleno Therapeutics, Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Soleno Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports